Type 2 diabetes increases the risk of chronic kidney disease, making prevention of kidney failure a key part of treatment. Newer diabetes medications, including GLP-1s and SGLT2 inhibitors, can reduce the risk of kidney disease, but previous studies have included large proportions of patients who already had signs of kidney damage, making it unclear whether the findings applied to patients without kidney damage.
❓ Unknown
Urine Test May Enhance Kidney Protection in Type 2 Diabetes Treatment
Just now
September 17, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A new urine test could help guide kidney-protective treatment options for type 2 diabetes patients, which is significant as diabetes is a growing health concern in Iran. The study highlights the effectiveness of newer diabetes medications in preventing kidney disease. This is crucial for improving healthcare outcomes in Iran, where chronic kidney disease is prevalent among diabetes patients.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
14 min ago •
Brazilian Sedge Reproduces Sexually Without Genetic Reshuffling, Producing Clonal Offspring
14 min ago •
H5N1 Bird Flu Claims Life of Australian Sea Lion, Raises Concerns for Marine Wildlife
24 min ago •
Palestinians Rely on Local Radio for Updates Amid Israeli Attacks
24 min ago •
Scientists Successfully Transport Antiprotons by Road for the First Time
24 min ago •